跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HYCAMTIN Topotecan (as hydrochloride) 4mg powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
HYCAMTIN Topotecan (as hydrochloride) 4mg powder for injection vial
Approved
STANDARD
HYCAMTIN Topotecan (as hydrochloride) 4mg powder for injection vial
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
d598fc347f507f39
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
d598fc347f507f39
Product Name
HYCAMTIN Topotecan (as hydrochloride) 4mg powder for injection vial
Artg Id
58598
Artg Name
HYCAMTIN Topotecan (as hydrochloride) 4mg powder for injection vial
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
1997-03-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/93e826cc7648bfa3f69c9c41bb697073.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/939bada94b9f64cd4fba111f649a5265.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
d598fc347f507f39
Type
Standard
Back to TGA Approvals
